Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | InClin Selects SimpleCTMS For Clinical Study Management OptimizationInClin, a San Francisco Bay Area Clinical Research Organization (CRO), has selected SimpleCTMS, a leading eClinical study management solution, as part of a growing initiative to enhance their clinical research service offering.
Having collaborated with more than 90 sponsor companies on over 200 trials, including more than 50 pivotal Phase 2 and Phase 3 studies, InClin has a reputation for on time performance that delivers within their client’s budget. With SimpleCTMS in place, InClin expects to continue to deliver upon their strong performance record while also further refining and standardizing key company infrastructure needs. “We are delighted to continue the collaborative and positive arrangement with InClin. Their top-notch quality and management of all study activities on behalf of fast-paced clients is a perfect match for the full-featured functionality of SimpleCTMS,” About InClin Established in 1998, InClin is a premier North American Clinical Research Organization (CRO) that provides Phase 1 – 4 clinical research services to the pharmaceutical, biotechnology, and medical device industries. With broad multidisciplinary training, the senior management team of InClin has the insight, integrity and ingenuity to assist its clients in the design and execution of sound clinical programs. For more information, please visit http://www.inclin.com. About Trial By Fire Solutions Trial By Fire Solutions is a life sciences focused clinical software company featuring SimpleCTMS, a flexible, intuitive and powerful clinical trial management system (CTMS). With a passion for innovating web-based eClinical technology, Trial By Fire Solutions develops applications to optimize planning, execution, tracking and overall cost of clinical trials. For more information, please visit http://www.simplectms.com. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|